Myeloablative Total Body Irradiation (TBI)
Overview
Myeloablative Total Body Irradiation (TBI) is a specialized radiation therapy used as part of the conditioning regimen for allogeneic hematopoietic stem cell transplantation (HSCT) in patients with leukemia and other blood cancers and disorders. TBI delivers radiation to the entire body, targeting both cancerous cells and the bone marrow, to prepare the body for the transplant. The therapy is carefully planned to ensure accurate dosing and safe delivery. Depending on the patient's age, disease, and transplant type, various dose and fractionation schedules are used.
Since TBI involves irradiating the entire body, precautions are taken to protect critical organs and limit side effects. Myeloablative TBI is typically administered over several days to reduce toxicity and allow for precise treatment.
Online
Call
WhatsApp
Family Hifazat AppConditions We Treat
Aplastic anaemia (inability of bone marrow to produce blood cells)
Thalassemia major (genetic blood disorder)
Leukemia (cancer of the blood and bone marrow)
Lymphoma (cancer of the lymphatic system)
Other blood and bone marrow disorders
To learn more about our highly trained and skilled experts, search on Find a Doctor under the speciality of Radiation Oncology.
If you have been diagnosed with cancer and are considering stem cell transplant, contact AKUH to learn more about Myeloablative Total Body Irradiation (TBI) and discuss your treatment options with our team.
)
){kind=logo}
){kind=logo}